Submitted by Anonymous (not verified) on 5 December 2023 - 13:33
Human medicines European public assessment report (EPAR): Shingrix, herpes zoster vaccine (recombinant, adjuvanted), Date of authorisation: 21/03/2018, Revision: 10, Status: Authorised
Source: